Cargando…

Mechanisms of chemotherapy resistance in ovarian cancer

Ovarian cancer is one of the most lethal gynecologic cancers. The standard therapy for ovarian cancer has been the same for the past two decades, a combination treatment of platinum with paclitaxel. Recently, the FDA approved three new therapeutic drugs, two poly (ADP-ribose) polymerase inhibitors (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz, Mylena, Wabel, Emma, Mitchell, Kerry, Horibata, Sachi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255249/
https://www.ncbi.nlm.nih.gov/pubmed/35800369
http://dx.doi.org/10.20517/cdr.2021.147